Viking Therapeutics Cash Flow Statement (2014-2026) | VKTX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-0.02B	-0.01B	-0.01B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.03B	-0.02B	-0.03B	-0.04B	-0.05B	-0.07B	-0.09B	-0.16B	-0.16B
Share-based Compensation (Quarter)	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B
Gains from Sales and Divestitures (Quarter)		0.00B		0.00B					0.00B	0.00B		0.00B			0.00B			0.00B	0.00B	0.00B
Gains from Investment Securities (Quarter)	0.00B	0.00B		0.00B	0.00B	0.01B	0.00B				-0.01B	0.01B	0.00B	0.00B	0.00B	0.01B	0.01B	0.00B	-0.00B
Non-cash Items (Quarter)	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.02B	0.00B	0.00B	23.33B	0.06B	0.40B	0.00B	0.26B	0.14B	0.00B	0.00B	0.00B	0.00B	0.10B
Cash from Operations (Quarter)	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.02B	-0.01B	-0.02B	-0.02B	-0.01B	-0.03B	-0.02B	-0.03B	-0.05B	-0.05B	-0.09B	-0.09B	-0.11B
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	0.00B	0.00B	-0.00B	-0.00B	-0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B	0.02B	0.00B	-0.00B	0.00B	0.00B	0.00B
Amortization of Deferred Charges (Quarter)	0.00B	0.00B	0.00B	0.00B
Change in Working Capital
Change in Account Payables (Quarter)	-0.00B	-0.00B	-0.00B	0.00B	0.00B	-0.00B	0.01B	-0.00B	0.00B	0.00B	0.00B	-0.00B	0.01B	-0.01B	0.01B	-0.00B	-0.00B	-0.00B	0.05B	0.01B
Change in Accured Expenses (Quarter)	0.00B	-0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B	-0.00B	-0.00B	0.00B	0.02B	-0.01B	0.01B	-0.01B	-0.01B	0.01B	-0.00B	0.00B	0.02B
Investing Activities
Change in Acquisitions & Divestments (Quarter)	0.06B	0.04B	0.06B	0.03B	0.05B	0.04B	0.05B	0.06B	0.04B	0.07B	0.13B	0.14B	0.10B	0.18B	0.14B	0.30B	0.17B	0.18B	0.12B	0.13B
Cash from Investing Activities (Quarter)	0.00B	0.01B	0.03B	0.00B	0.02B	0.03B	0.01B	0.00B	-0.20B	-0.01B	0.04B	-0.46B	-0.13B	0.03B	0.01B	0.06B	0.04B	0.16B	0.08B	0.05B
Financing Activities
Other financing activities (Quarter)			0.00B					0.00B
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
Long-Term Debt Repayments (Quarter)
Change in Capital Stock
Shares Issued (Quarter)	0.00B	0.00B	0.00B	0.00B	0.00B		0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Shares Repurchased (Quarter)				0.01B	0.00B
Misc.
Cash from Financing Activities (Quarter)	0.00B	-0.00B	0.00B	-0.01B	-0.00B	0.00B	0.01B	0.00B	0.27B	-0.00B	0.00B	0.61B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.08B	0.01B
Exchange Rate Effect (Quarter)						-0.00B	0.00B	-0.00B	-0.00B	-0.00B	0.00B	-0.00B	0.00B	-0.00B	-0.00B	0.00B	-0.00B	-0.00B	0.00B	0.00B
Change in Cash (Quarter)	-0.01B	0.00B	0.02B	-0.01B	0.00B	0.01B	0.01B	-0.02B	0.05B	-0.03B	0.02B	0.14B	-0.15B	0.01B	-0.02B	0.01B	-0.00B	0.07B	0.07B	-0.05B
Free Cash Flow (Quarter)	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.02B	-0.01B	-0.02B	-0.02B	-0.01B	-0.03B	-0.02B	-0.03B	-0.05B	-0.05B	-0.09B	-0.09B	-0.11B
Net Cash Flow (Quarter)	-0.01B	0.00B	0.02B	-0.01B	0.00B	0.01B	0.01B	-0.02B	0.05B	-0.03B	0.02B	0.14B	-0.15B	0.01B	-0.02B	0.01B	-0.00B	0.07B	0.07B	-0.05B

Research Tools

Viking Therapeutics Cash Flow Statement (2014-2026) | VKTX

Create an account

Sign In

Reset Password